Last Price
354.10
Today's Change
+3.30 (0.94%)
Day's Change
350.60 - 359.70
Trading Volume
21,597,744
Overview
Market Cap
31 Billion
Shares Outstanding
8 Billion
Avg Volume
21,017,477
Avg Price (50 Days)
347.31
Avg Price (200 Days)
374.23
PE Ratio
20.83
EPS
0.17
Earnings Announcement
25-Feb-2026
Previous Close
350.80
Open
350.80
Day's Range
350.6 - 359.7
Year Range
274.4 - 419.5
Trading Volume
21,724,914
Price Change Highlight
1 Day Change
0.94%
5 Day Change
1.78%
1 Month Change
7.40%
3 Month Change
-3.09%
6 Month Change
-11.12%
Ytd Change
-6.52%
1 Year Change
-4.76%
3 Year Change
32.60%
5 Year Change
14.84%
10 Year Change
14.84%
Max Change
14.84%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Discussions
Be the first to like this.
Showing 0 of 0 comments
Post a Comment
Latest Videos
![[New IPO] Insights Analytics Berhad, a provider of automated test and intelligent asset management solutions for the E&E and water management sectors, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1300/Thumbnail__(8).png)
Apps
Top Articles
1
Stumbling and Mumbling
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
{uid}
{comment}
Just now